NCT07132177View on ClinicalTrials.gov

Targeted Naltrexone to Support Individuals Participating in Dry January

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

May 1, 2026

Conditions
Alcohol Misuse
Interventions
DRUG

Naltrexone (oral tablets)

All participants will receive 31 pills of 50 mg Naltrexone to take as needed over the month of January 2026.

Trial Locations (1)

02115

Brigham and Women's hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER